A genetic approach to stratification of risk for age-related macular degeneration.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Canadian Journal of Ophthalmology-journal Canadien D Ophtalmologie

• Publication date

  2010-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3129/i09-209PMID 20130705
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Age-Related Eye Disease Study と加齢黄斑変性におけるサプリメントガイドライン

  2012cited by this paper
• Mitochondrial DNA haplogroups associated with age-related macular degeneration.

  2009cited by this paper
• Common variation in the SERPING1 gene is not associated with age-related macular degeneration in two independent groups of subjects

  2009cited by this paper
• An Open Access Database of Genome-wide Association Results

  2009cited by this paper
• HECTD2, a candidate susceptibility gene for Alzheimer's disease on 10q

  2009cited by this paper
• Complement component C3 and risk of age-related macular degeneration.

  2009cited by this paper
• Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables.

  2009cited by this paper
• Analysis of rare variants in the complement component 2 (C2) and factor B (BF) genes refine association for age-related macular degeneration (AMD).

  2009cited by this paper
• Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study.

  2009cited by this paper
• Characteristics of choroidal neovascularization in the complications of age-related macular degeneration prevention trial.

  2008cited by this paper
• Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study.

  2008cited by this paper
• Mitochondrial DNA Polymorphism A4917G Is Independently Associated with Age-Related Macular Degeneration

  2008cited by this paper
• Power and SNP tagging in whole mitochondrial genome association studies.

  2008cited by this paper
• Systemic Complement Activation in Age-Related Macular Degeneration

  2008cited by this paper
• Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA

  2008cited by this paper
• Alzheimer disease and the role of free radicals in the pathogenesis of the disease.

  2008influential reference
• Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology.

  2008cited by this paper
• Impaired Opsonization with C3b and Phagocytosis of Streptococcus pneumoniae in Sera from Subjects with Defects in the Classical Complement Pathway

  2008cited by this paper
• Mechanism of oxidative DNA damage repair and relevance to human pathology.

  2008cited by this paper
• Variation in complement factor 3 is associated with risk of age-related macular degeneration

  2007cited by this paper
• Complement C3 variant and the risk of age-related macular degeneration.

  2007cited by this paper
• Complement deficiencies and systemic lupus erythematosus

  2007cited by this paper
• A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration

  2007cited by this paper
• The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22.

  2007cited by this paper
• Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits.

  2007cited by this paper
• Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration.

  2007cited by this paper
• Burden of illness of neovascular age-related macular degeneration in Canada.

  2007cited by this paper
• Complement C 3 Variant and the Risk of Age-Related Macular Degeneration

  2007cited by this paper
• Germ-line DNA copy number variation frequencies in a large North American population

  2007cited by this paper
• THE SIGNIFICANCE OF EARLY DETECTION OF AGE-RELATED MACULAR DEGENERATION: Richard & Hinda Rosenthal Foundation Lecture, The Macula Society 29th Annual Meeting

  2007cited by this paper
• Base-excision repair of oxidative DNA damage

  2007cited by this paper
• A Variant of the HTRA1 Gene Increases Susceptibility to Age-Related Macular Degeneration

  2006influential reference
• CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration

  2006influential reference
• A Statistical Model for Assessing Genetic Susceptibility as a Risk Factor in Multifactorial Diseases: Lessons from Occupational Asthma

  2006cited by this paper
• Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration

  2006cited by this paper
• A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.

  2005cited by this paper
• Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk.

  2005cited by this paper
• Complement Factor H Polymorphism in Age-Related Macular Degeneration

  2005cited by this paper
• Prevalence of age-related macular degeneration in the United States.

  2004cited by this paper
• Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19.

  2003cited by this paper
• Age-related macular degeneration--a genome scan in extended families.

  2003cited by this paper
• Complement. Second of two parts.

  2001cited by this paper
• Complement. First of two parts.

  2001cited by this paper
• Initial sequencing and analysis of the human genome

  2001cited by this paper
• Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study.

  1998cited by this paper
• First of two parts

  1997cited by this paper
• Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.

  1995cited by this paper
• Prevalence of age-related maculopathy. The Beaver Dam Eye Study.

  1992cited by this paper

• Bridging the gap of vision restoration

  2024cites this paper
• The Impact of NF-κB on Inflammatory and Angiogenic Processes in Age-Related Macular Degeneration.

  2024cites this paper
• Can the Onset of Neovascular Age-Related Macular Degeneration Be an Acceptable Endpoint for Prophylactic Clinical Trials?

  2020cites this paper
• Utility of the “omics” in kidney disease: Methods of analysis, sampling considerations, and technical approaches in renal biomarkers

  2020cites this paper
• How Do Patients Respond to Genetic Testing for Age-related Macular Degeneration?

  2018cites this paper
• Risk of elevated intraocular pressure after ranibizumab injection in patients with neovascular age-related macular degeneration

  2017cites this paper
• Chapter 18 – Molecular Genetic Testing and the Future of Clinical Genomics1

  2017cites this paper
• Toward personalized medicine in age-related macular degeneration

  2016cites this paper
• A Value-Based Medicine cost-utility analysis of genetic testing for neovascular macular degeneration

  2015cites this paper
• Combined effects of genetic and non‐genetic risk factors affect response to ranibizumab in exudative age‐related macular degeneration

  2015cites this paper
• Direct-to-consumer personal genome testing for age-related macular degeneration.

  2014cites this paper
• CURRENT KNOWLEDGE AND TRENDS IN AGE-RELATED MACULAR DEGENERATION: Genetics, Epidemiology, and Prevention

  2014influential citation
• Association of Single Nucleotide Polymorphisms in CFH, ARMS2 and HTRA1 Genes with Risk of Age-related Macular Degeneration in Egyptian Patients

  2013cites this paper
• Calculadora de riesgo de evolución a DMAE avanzada. Aplicación en práctica clínica habitual Risk calculator for the progression of advanced age-related macular degeneration. Application in the daily clinical practice

  2013cites this paper
• Molecular genetic testing and the future of clinical genomics

  2013cites this paper
• Risk alleles in CFH and ARMS2 and the long-term natural history of age-related macular degeneration: the Beaver Dam Eye Study.

  2013cites this paper
• Age-related macular degeneration revisited--piecing the puzzle: the LXIX Edward Jackson memorial lecture.

  2013cites this paper
• Prediction of age-related macular degeneration in the general population: the Three Continent AMD Consortium.

  2013cites this paper
• Genetic risk factors and age-related macular degeneration (AMD)

  2013cites this paper
• Genetic studies of age-related macular degeneration: lessons, challenges, and opportunities for disease management.

  2012cites this paper
• Association of ARMS2 genotype with bilateral involvement of exudative age-related macular degeneration.

  2012cites this paper
• Oxidative stress: the achilles' heel of neurodegenerative diseases of the retina.

  2012cites this paper
• Update on the role of genetics in the onset of age-related macular degeneration

  2011cites this paper
• Risk assessment model for development of advanced age-related macular degeneration.

  2011influential citation
• Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration

  2011cites this paper
• A role for epigenetic changes in the development of retinal neurodegenerative conditions

  2011cites this paper
• ROLE OF LUTEIN IN INHIBITING ENDOGENOUS OXIDATIVE DNA DAMAGE IN LYMPHOCYTES WITH THE OCCURRENCE OF AGE-RELATED MACULAR DEGENERATION Research Article

  2011cites this paper
• Advantages and disadvantages of molecular testing in

  2011cites this paper
• Advantages and disadvantages of molecular testing in ophthalmology

  2011cites this paper
• Risk assessment models for late age-related macular degeneration.

  2011cites this paper
• Update on the role of genetics in the onset of age-related macular degeneration

  2011cites this paper
• Lack of association of CFD polymorphisms with advanced age-related macular degeneration

  2010cites this paper